Another oncologic medication with a specific renal side effect is gemcitabine (Gemzar), a nucleoside analogue used with frequency to treat cancer of the lung, pancreas, breast and colon to name a few. Gemcitabine can cause a thrombotic microangiopathy, having been reported at an incidence of 0.31% according to a paper by Humphreys et al (in Cancer 2004). It should be considered in any cancer patient receiving this medication with new onset renal failure, hypertension, or thrombocytopenia.
No comments:
Post a Comment
Renal Fellow Network encourages comments and discussion regarding the posts. Do not post any comments that are commercial or advertising in nature. Posts will be deleted if commercial or advertising comments are made. Internet users commenting on the Renal Fellow Network must post information which is true and correct to their knowledge. Sources to health/medical claims must be provided when relevant. Moderators reserve the right to erase, without notification, any comment they would judge inappropriate.